London: According to the latest updated data from Public Health England (PHE), London recorded the highest increase in case rates per 100,000 population across England with 602.2 in week 51 compared to 361.8 in the previous week.
The weekly report, which monitors Covid-19, influenza and other seasonal respiratory viruses in England, is based on data from week 51 (between 14 and 20 December) and for some indicators daily data up to 22 December, l ‘Xinhua news agency reported on Thursday.
According to the report, case rates per 100,000 have increased in all regions of England and are the highest in London with a rate of 602.2 per 100,000 population.
Case rates also increased across all age groups, with the highest rate being 434.6 per 100,000 population aged 30 to 39.
The hospital admission rate for Covid-19 was 18.66 per 100,000 in week 51, compared with 15.18 per 100,000 in the previous week, the report said.
Hospital admission rates for Covid-19 have increased in all regions except the north east of England, but this region also has the highest rate of 23.44, the PHE said.
More than 2,100 patients with Covid-19 were admitted to London hospitals in one week and cases have soared by almost 56,000, according to official figures.
The data shows a growing number of people affected by the virus needing hospital treatment, with 357 hospitalized in city hospitals on December 18 and 366 the day before.
“This won’t be a normal Christmas for any of us. If you meet loved ones, try to keep your distance, wash your hands thoroughly and more often, and ventilate as much as possible, ”said Yvonne Doyle, PHE’s medical director.
Level four restrictions
London and much of England are currently subject to level four restrictions, the highest level.
Under the new stricter measures, residents in Level Four areas are required to stay at home, with limited exemptions. People are also encouraged to work from home when they can and should not enter or leave those areas.
To bring life back to normal, countries like Britain, China, Germany, Russia and the United States are racing against time to develop coronavirus vaccines.